tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ANIP Stock Latest News

ANI Pharmaceuticals price target raised to $124 from $115 at Guggenheim
The FlyANI Pharmaceuticals price target raised to $124 from $115 at Guggenheim
1d ago
ANIP
ANI Pharmaceuticals issues strong 2025 preliminary results, 2026 outlook
PremiumCompany Announcements
ANI Pharmaceuticals issues strong 2025 preliminary results, 2026 outlook
5d ago
8K
ANIP
ANI Pharmaceuticals sees FY26 revenue $1.055B-$1.115B, consensus $955.04M.
PremiumThe Fly
ANI Pharmaceuticals sees FY26 revenue $1.055B-$1.115B, consensus $955.04M.
5d ago
ANIP
ANI Pharmaceuticals sees FY23 EPS, revenue ‘within or above guidance ranges’
PremiumThe Fly
ANI Pharmaceuticals sees FY23 EPS, revenue ‘within or above guidance ranges’
5d ago
ANIP
ANI Pharmaceuticals Announces Leadership Transition in Board
PremiumCompany Announcements
ANI Pharmaceuticals Announces Leadership Transition in Board
2M ago
8K
ANIP
ANI Pharmaceuticals chairman Patrick Walsh to retire, Thomas Haughey to succeed
PremiumThe FlyANI Pharmaceuticals chairman Patrick Walsh to retire, Thomas Haughey to succeed
2M ago
ANIP
ANI Pharmaceuticals Highlights November 2025 Financial Strategies
Premium
Company Announcements
ANI Pharmaceuticals Highlights November 2025 Financial Strategies
2M ago
8K
ANIP
ANI Pharmaceuticals price target raised to $115 from $114 at Guggenheim
Premium
The Fly
ANI Pharmaceuticals price target raised to $115 from $114 at Guggenheim
2M ago
ANIP
ANI Pharmaceuticals’ Earnings Call Highlights Record Growth
PremiumCompany Announcements
ANI Pharmaceuticals’ Earnings Call Highlights Record Growth
2M ago
ANIP
ANI Pharmaceuticals Reports Record Q3 2025 Results
PremiumCompany Announcements
ANI Pharmaceuticals Reports Record Q3 2025 Results
2M ago
ANIP
ANI Pharmaceuticals: Strong Commercial Execution and Promising Growth Prospects Reinforce Buy Rating
PremiumRatings
ANI Pharmaceuticals: Strong Commercial Execution and Promising Growth Prospects Reinforce Buy Rating
2M ago
ANIP
ANI Pharmaceuticals raises FY25 adj. EPS view to $7.37-$7.64 from $6.98-$7.35
PremiumThe Fly
ANI Pharmaceuticals raises FY25 adj. EPS view to $7.37-$7.64 from $6.98-$7.35
2M ago
ANIP
ANI Pharmaceuticals reports Q3 adjusted EPS $2.04, consensus $1.77
PremiumThe FlyANI Pharmaceuticals reports Q3 adjusted EPS $2.04, consensus $1.77
2M ago
ANIP
ANIP Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
ANIP Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
ANIP
ANI Pharmaceuticals price target raised to $90 from $77 at Truist
Premium
The Fly
ANI Pharmaceuticals price target raised to $90 from $77 at Truist
3M ago
ANIP
ANI Pharmaceuticals Completes Mandatory Conversion of Preferred Shares
PremiumCompany Announcements
ANI Pharmaceuticals Completes Mandatory Conversion of Preferred Shares
4M ago
8K
ANIP
Strong Growth Potential for ANI Pharmaceuticals Driven by Cortrophin Gel and Strategic Expansion
PremiumRatings
Strong Growth Potential for ANI Pharmaceuticals Driven by Cortrophin Gel and Strategic Expansion
4M ago
ANIP
ANI Pharmaceuticals price target raised to $115 from $95 at JPMorgan
PremiumThe Fly
ANI Pharmaceuticals price target raised to $115 from $95 at JPMorgan
4M ago
ANIP
ANI Pharmaceuticals price target raised to $121 from $93 at H.C. Wainwright
PremiumThe Fly
ANI Pharmaceuticals price target raised to $121 from $93 at H.C. Wainwright
4M ago
ANIP
ANI Pharmaceuticals price target raised to $114 from $86 at Guggenheim
PremiumThe FlyANI Pharmaceuticals price target raised to $114 from $86 at Guggenheim
4M ago
ANIP
ANI Pharmaceuticals Highlights Commercialization Focus Amid Challenges
Premium
Company Announcements
ANI Pharmaceuticals Highlights Commercialization Focus Amid Challenges
4M ago
8K
ANIP
ANI Pharmaceuticals’ Record Earnings and Optimistic Outlook
Premium
Company Announcements
ANI Pharmaceuticals’ Record Earnings and Optimistic Outlook
5M ago
ANIP

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >